Figure 2.

Edelfosine targets early embryonic development. (A) Percentage of surviving embryos (n ≥ 100 per treatment) laid by control worms or by worms treated with edelfosine. Different groups of age-synchronized worms are treated at different points of development or adulthood. Each bar in the histogram represents the mean values ± SD of at least 3 independent experiments. (B) Percentage of surviving embryos (n = 60–130 per treatment) when embryos are treated with edelfosine at different times of “ex utero” embryogenesis. Each bar in the histogram represents the mean values ± SD of at least 3 independent experiments.